메뉴 건너뛰기




Volumn 83, Issue 2, 2000, Pages 176-177

Cost-benefit analysis is the key

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

EID: 0033843669     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.83.2.176     Document Type: Short Survey
Times cited : (3)

References (15)
  • 1
    • 0038277786 scopus 로고    scopus 로고
    • Endocrine assessment
    • Kelnar CJH, Savage MO, Stirling HF, Saenger P, eds. Growth disorders: Pathophysiology and treatment. London: Chapman and Hall
    • (1998) , pp. 237-250
    • Hindmarsh, P.C.1
  • 3
    • 0001817840 scopus 로고    scopus 로고
    • Idiopathic short stature-diagnostic and therapeutic dilemmas
    • Royal Society of Medicine Current Medical Literature, Growth hormone and growth factors. London: Royal Society of Medicine
    • (1999) , vol.14 , pp. 61-65
    • Hailey, J.A.1    Bath, L.E.2    Kelnar, C.J.H.3
  • 11
    • 0000006365 scopus 로고    scopus 로고
    • Adverse events during GH treatment: 10 years' experience in KIGS, a pharmacoepidemiological survey
    • Ranke MB, Wilton P, eds. Growth hormone therapy in KIGS - 10 years' experience. Mannheim: Barth (Edition J and J)
    • (1999) , pp. 349-364
    • Wilton, P.1
  • 14
    • 0008186011 scopus 로고    scopus 로고
    • Quality of Practice Committee, Royal College of Paediatrics and Child Health
    • Standards for development of clinical practice guidelines in paediatrics and child health London RCPCH Publications
  • 15
    • 0033372196 scopus 로고    scopus 로고
    • The ethical dilemma of growth hormone treatment of short stature: A scientific theoretical approach
    • (1999) Horm Res , vol.51 , pp. 301-304
    • Haverkamp, F.1    Ranke, M.B.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.